KO | Aktsiad | 641,772 mld. | — | KO KoAct | 0 | Tervishoid | | 3.8.2023 | 23 407,33 | 9,78 | 37,04 |
TE | Aktsiad | 320,579 mld. | — | TE Tiger ETF | 0,40 | Tervishoid | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 9261,77 | 5,68 | 62,93 |
KO | Aktsiad | 310,513 mld. | — | KO KODEX | 0,45 | Tervishoid | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 13 492,45 | 6,80 | 37,93 |
TE | Aktsiad | 222,966 mld. | — | TE Tiger ETF | 0,40 | Tervishoid | KRX Healthcare - KRW | 15.7.2011 | 54 183,82 | 5,37 | 46,27 |
KO | Aktsiad | 107,703 mld. | — | KO KODEX | 0,09 | Tervishoid | KRX Healthcare - KRW | 28.3.2017 | 24 603,29 | 5,37 | 46,25 |
TE | Aktsiad | 103,728 mld. | — | TE Tiger ETF | 0,30 | Tervishoid | NASDAQ Biotechnology Index | 26.8.2014 | 30 540,84 | 5,37 | 23,71 |
TE | Aktsiad | 95,184 mld. | — | TE Tiger ETF | 0,40 | Tervishoid | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 20 752,30 | 11,87 | 59,10 |
KO | Aktsiad | 64,895 mld. | — | KO KODEX | 0,25 | Tervishoid | S&P Health Care Select Sector | 21.3.2023 | 13 669,21 | 5,12 | 23,06 |
TE | Aktsiad | 64,391 mld. | — | TE Tiger ETF | 0,49 | Tervishoid | Solactive China Biotech Index | 3.12.2020 | 8751,63 | 4,34 | 39,11 |
KR | Aktsiad | 57,779 mld. | — | KR KB RISE | 0 | Tervishoid | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 16 542,05 | 9,56 | 68,04 |
TE | Aktsiad | 54,404 mld. | — | TE Tiger ETF | 0,45 | Tervishoid | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10 767,43 | 10,72 | 21,80 |
KO | Aktsiad | 50,739 mld. | — | KO KODEX | 0,45 | Tervishoid | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 11 416,87 | 6,18 | 16,57 |
SP | Aktsiad | 41,694 mld. | 11,96 mln. | SP SPDR | 0,08 | Tervishoid | S&P Health Care Select Sector | 16.12.1998 | 156,77 | 5,11 | 22,91 |
TE | Aktsiad | 37,142 mld. | — | TE Tiger ETF | 0,40 | Tervishoid | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 24 660,08 | 3,42 | 40,82 |
TE | Aktsiad | 31,446 mld. | — | TE Tiger ETF | 0 | Tervishoid | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 26 334,13 | 0 | 0 |
HW | Aktsiad | 28,179 mld. | — | HW Hwabao | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,36 | 3,06 | 30,88 |
KO | Aktsiad | 19,948 mld. | — | KO KODEX | 0,25 | Tervishoid | S&P Biotechnology Select Industry | 31.10.2013 | 38 613,38 | 0 | 0 |
NH | Aktsiad | 18,612 mld. | — | NH NH-Amundi | 0 | Tervishoid | | 26.11.2024 | 17 119,74 | 6,05 | 41,72 |
EF | Aktsiad | 18,095 mld. | — | EF E Fund | 0 | Tervishoid | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,39 | 3,37 | 26,68 |
VA | Aktsiad | 17,417 mld. | 269 668,6 | VA Vanguard | 0,09 | Tervishoid | MSCI US IMI 25/50 Health Care | 26.1.2004 | 291,45 | 4,95 | 23,18 |
KO | Aktsiad | 15,053 mld. | — | KO KoAct | 0,50 | Tervishoid | | 11.11.2025 | 10 266,63 | 5,77 | 0 |
KR | Aktsiad | 11,042 mld. | — | KR KB RISE | 0 | Tervishoid | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 19 367,63 | 5,38 | 42,23 |
AC | Aktsiad | 9,152 mld. | — | AC ACE | 0,30 | Tervishoid | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12 920,71 | 7,82 | 23,23 |
KI | Aktsiad | 8,876 mld. | — | KI Kiwoom | 0,49 | Tervishoid | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 14 409,04 | 0 | 0 |
AC | Aktsiad | 8,816 mld. | — | AC ACE | 0,45 | Tervishoid | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 12 516,95 | 4,01 | 26,25 |
IS | Aktsiad | 8,588 mld. | 1,726 mln. | IS iShares | 0,44 | Tervishoid | NYSE Biotechnology (TR) | 5.2.2001 | 174,34 | 5,58 | 24,85 |
SP | Aktsiad | 8,003 mld. | 9,098 mln. | SP SPDR | 0,35 | Tervishoid | S&P Biotechnology Select Industry | 31.1.2006 | 124,77 | 4,95 | 0 |
TE | Aktsiad | 7,031 mld. | — | TE Tiger ETF | 0,50 | Tervishoid | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 20 791,93 | 3,20 | 22,58 |
CH | Aktsiad | 6,857 mld. | — | CH ChinaAMC | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,84 | 3,00 | 21,32 |
BO | Aktsiad | 6,766 mld. | — | BO Bosera | 0,65 | Tervishoid | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,64 | 2,75 | 12,80 |
MA | Aktsiad | 6,668 mld. | — | MA Maxwealth | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,51 | 2,65 | 31,19 |
KI | Aktsiad | 5,866 mld. | — | KI Kiwoom | 0,49 | Tervishoid | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 597,64 | 4,74 | 18,54 |
NF | Aktsiad | 5,713 mld. | — | NF NEXT FUNDS | 0,32 | Tervishoid | | 21.3.2008 | 33 033,72 | 1,93 | 25,33 |
KR | Aktsiad | 5,547 mld. | — | KR KB RISE | 0,35 | Tervishoid | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9944,15 | 8,99 | 20,36 |
KO | Aktsiad | 5,482 mld. | — | KO KoAct | 0,50 | Tervishoid | | 3.9.2024 | 12 223,58 | 4,50 | 18,69 |
NI | Aktsiad | 5,441 mld. | — | NI Nippon | 0,19 | Tervishoid | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
IN | Aktsiad | 4,974 mld. | — | IN Invesco | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,69 | 3,45 | 24,61 |
TE | Aktsiad | 4,915 mld. | — | TE Tiger ETF | 0,40 | Tervishoid | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0 | 0 |
IC | Aktsiad | 4,755 mld. | — | IC ICBC | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,25 | 0 | 0 |
CH | Aktsiad | 4,753 mld. | — | CH ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 16,34 | 3,56 | 28,98 |
CH | Aktsiad | 4,661 mld. | — | CH ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,77 | 3,56 | 28,98 |
EF | Aktsiad | 4,382 mld. | — | EF E Fund | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,40 | 0 | 0 |
IS | Aktsiad | 4,297 mld. | 279 676,9 | IS iShares | 0,40 | Tervishoid | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 101,14 | 4,70 | 23,01 |
GU | Aktsiad | 3,769 mld. | — | GU Guotai | 0,60 | Tervishoid | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1,02 | 0 | 0 |
XT | Aktsiad | 3,617 mld. | — | XT Xtrackers | 0,25 | Tervishoid | MSCI World Index / Health Care -SEC | 22.11.2010 | 60,10 | 4,78 | 22,84 |
IS | Aktsiad | 3,592 mld. | 1,645 mln. | IS iShares | 0,38 | Tervishoid | DJ US Select / Medical Equipment | 1.5.2006 | 59,36 | 4,18 | 26,55 |
FU | Aktsiad | 3,364 mld. | — | FU Fullgoal | 0,60 | Tervishoid | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,44 | 0 | 0 |
IS | Aktsiad | 3,318 mld. | 703 053,1 | IS iShares | 0,38 | Tervishoid | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 65,53 | 5,20 | 23,41 |
FI | Aktsiad | 2,944 mld. | 183 916,4 | FI Fidelity | 0,08 | Tervishoid | MSCI US IMI 25/50 Health Care | 21.10.2013 | 75,23 | 5,00 | 23,10 |
IS | Aktsiad | 2,77 mld. | — | IS iShares | 0,15 | Tervishoid | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 12,55 | 5,15 | 23,07 |
NH | Aktsiad | 2,735 mld. | — | NH NH-Amundi | 0,45 | Tervishoid | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9115,65 | 3,43 | 26,31 |
HW | Aktsiad | 2,395 mld. | — | HW Hwabao | 0 | Tervishoid | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,57 mld. | 0 | 0 |
FT | Aktsiad | 2,383 mld. | 123 159 | FT First Trust | 0,54 | Tervishoid | NYSE Arca Biotechnology Index | 19.6.2006 | 208,42 | 3,63 | 25,32 |
GU | Aktsiad | 2,311 mld. | — | GU Guotai | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,45 | 3,06 | 30,91 |
PA | Aktsiad | 1,874 mld. | — | PA Ping An | 0,60 | Tervishoid | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,37 | 4,10 | 25,08 |
EF | Aktsiad | 1,701 mld. | — | EF E Fund | 0,20 | Tervishoid | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,14 | 2,50 | 20,25 |
HE | Aktsiad | 1,661 mld. | — | HE Harvest ETFs | 1,06 | Tervishoid | | 19.11.2014 | 7,64 | 4,93 | 21,81 |
IS | Aktsiad | 1,585 mld. | — | IS iShares | 0,18 | Tervishoid | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 7,64 | 4,24 | 21,39 |
AM | Aktsiad | 1,49 mld. | — | AM Amundi | 0,50 | Tervishoid | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9937,75 | 2,82 | 14,76 |
CA | Aktsiad | 1,461 mld. | — | CA Cathay | 1,05 | Tervishoid | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,15 | 3,36 | 18,14 |
GU | Aktsiad | 1,439 mld. | — | GU Guotai | 0,60 | Tervishoid | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,89 | 0 | 0 |
IS | Aktsiad | 1,428 mld. | — | IS iShares | 0,46 | Tervishoid | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 141,14 | 0 | 0 |
EF | Aktsiad | 1,413 mld. | — | EF E Fund | 0,20 | Tervishoid | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,51 | 2,78 | 29,20 |
EF | Aktsiad | 1,388 mld. | — | EF E Fund | 0,20 | Tervishoid | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,42 | 4,33 | 29,55 |
VA | Aktsiad | 1,336 mld. | 424 786,2 | VA VanEck | 0,36 | Tervishoid | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 110,39 | 5,21 | 20,15 |
EF | Aktsiad | 1,227 mld. | — | EF E Fund | 0,20 | Tervishoid | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,67 | 3,12 | 28,62 |
XT | Aktsiad | 1,191 mld. | — | XT Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 63,25 | 5,33 | 23,99 |
XT | Aktsiad | 1,176 mld. | — | XT Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 62,87 | 5,31 | 23,12 |
HA | Aktsiad | 1,084 mld. | — | HA Harvest | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,90 | 0 | 0 |
IS | Aktsiad | 1,04 mld. | 107 236 | IS iShares | 0,38 | Tervishoid | DJ US Select / Pharmaceutical | 1.5.2006 | 89,80 | 4,78 | 24,04 |
GX | Aktsiad | 972,319 mln. | — | GX Global X | 0,59 | Tervishoid | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1705,67 | 2,09 | 21,22 |
AM | Aktsiad | 965,555 mln. | — | AM Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 161,95 | 3,16 | 19,03 |
AM | Aktsiad | 965,555 mln. | — | AM Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 161,95 | 3,16 | 19,03 |
IS | Aktsiad | 934,804 mln. | — | IS iShares | 0,35 | Tervishoid | NASDAQ / Biotechnology | 19.10.2017 | 8,83 | 0 | 0 |
CS | Aktsiad | 921,083 mln. | — | CS CSOP | 1,50 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,79 | 3,52 | 28,95 |
FT | Aktsiad | 919,33 mln. | 29 986,87 | FT First Trust | 0,62 | Tervishoid | StrataQuant Health Care Index | 8.5.2007 | 115,77 | 2,84 | 16,99 |
WA | Aktsiad | 904,189 mln. | — | WA Wanjia | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,63 | 3,45 | 24,61 |
AM | Aktsiad | 782,122 mln. | — | AM Amundi | 0,30 | Tervishoid | MSCI World Index / Health Care -SEC | 19.8.2010 | 494,20 | 7,68 | 29,88 |
IN | Aktsiad | 769,019 mln. | 93 317,16 | IN Invesco | 0,40 | Tervishoid | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 32,87 | 3,30 | 21,29 |
IS | Aktsiad | 768,764 mln. | — | IS iShares | 0,46 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 122,76 | 4,16 | 21,44 |
IS | Aktsiad | 730,564 mln. | 299 436,1 | IS iShares | 0,38 | Tervishoid | DJ US Select / Health Care Providers | 1.5.2006 | 46,04 | 2,26 | 16,51 |
CA | Aktsiad | 706,372 mln. | — | CA Cathay | 0,41 | Tervishoid | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,44 | 0 | 0 |
SP | Aktsiad | 682,94 mln. | — | SP SPDR | 0,18 | Tervishoid | MSCI Europe Health Care Index - EUR | 5.12.2014 | 242,38 | 4,25 | 21,39 |
GX | Aktsiad | 673,241 mln. | — | GX Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 72,57 | 4,53 | 43,83 |
SP | Aktsiad | 665,111 mln. | — | SP SPDR | 0,30 | Tervishoid | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 69,39 | 5,08 | 25,68 |
GX | Aktsiad | 659,757 mln. | — | GX Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 71,98 | 4,53 | 43,83 |
CS | Aktsiad | 586,867 mln. | — | CS China Southern | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,20 | 2,97 | 21,35 |
SP | Aktsiad | 577,975 mln. | — | SP SPDR | 0,15 | Tervishoid | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 48,42 | 5,11 | 22,91 |
IS | Aktsiad | 570,301 mln. | — | IS iShares | 0,66 | Tervishoid | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 72,14 | 0 | 0 |
CH | Aktsiad | 567,457 mln. | — | CH ChinaAMC | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,88 | 2,65 | 31,16 |
DI | Aktsiad | 556,811 mln. | 608 183,1 | DI Direxion | 0,93 | Tervishoid | S&P Biotechnology Select Industry | 28.5.2015 | 166,51 | 0 | 0 |
FU | Aktsiad | 541,195 mln. | — | FU Fullgoal | 0,60 | Tervishoid | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,94 | 0 | 0 |
PB | Aktsiad | 514,14 mln. | 45 177,33 | PB Portfolio Building Block | 0,13 | Tervishoid | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 24.11.2025 | 26,96 | 5,64 | 22,11 |
GU | Aktsiad | 504,775 mln. | — | GU Guotai | 0,60 | Tervishoid | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,76 | 3,51 | 27,58 |
IN | Aktsiad | 442,211 mln. | — | IN Invesco | 0,40 | Tervishoid | NASDAQ / Biotechnology | 6.11.2014 | 63,09 | 5,31 | 23,64 |
CS | Aktsiad | 427,701 mln. | — | CS China Southern | 0,20 | Tervishoid | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,66 | 3,12 | 28,62 |
MA | Aktsiad | 421,723 mln. | — | MA Maxwealth | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,53 | 0 | 0 |
IN | Aktsiad | 418,433 mln. | 46 155,16 | IN Invesco | 0,57 | Tervishoid | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 108,14 | 3,10 | 19,80 |
IN | Aktsiad | 408,824 mln. | — | IN Invesco | 0,14 | Tervishoid | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 772,46 | 5,10 | 22,93 |
VA | Aktsiad | 389,159 mln. | 6857,645 | VA VanEck | 0,35 | Tervishoid | MVIS US Listed Biotech 25 | 20.12.2011 | 197,02 | 5,01 | 24,93 |